Long-term morbidity of infants with bronchopulmonary dysplasia

Pediatrics
|November 1, 1985
PubMed

Insights

Infants with bronchopulmonary dysplasia face higher mortality and ongoing health issues after hospital discharge. Close follow-up care is crucial for managing these chronic conditions and potentially preventing further complications.

Area of Science:

  • Neonatal intensive care
  • Pediatric pulmonology
  • Long-term infant health outcomes

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant concern for infants in neonatal intensive care units.
  • Understanding long-term outcomes for BPD survivors is essential for improving care.

Purpose of the Study:

  • To compare perinatal and outcome factors of infants with bronchopulmonary dysplasia to matched controls.
  • To identify key areas of ongoing morbidity and mortality in BPD survivors.

Main Methods:

  • Retrospective case-control study comparing 179 infants with BPD to 112 matched controls.
  • Analysis of demographic, diagnostic, and therapeutic factors, categorized as pulmonary and nonpulmonary.
  • Comparison of postdischarge death rates and ongoing health issues.

Main Results:

  • BPD infants had a significantly higher postdischarge death rate (11.2%) compared to controls (0.9%).
  • Ongoing morbidity was most prominent in health history, physical examination, growth, and vision.
  • Neurodevelopmental and hearing abnormalities were slightly more frequent but not statistically significant.

Conclusions:

  • Infants with bronchopulmonary dysplasia experience substantial postdischarge morbidity and mortality.
  • These outcomes suggest a need for close, ongoing postdischarge observation and care.
  • Preventable factors contributing to morbidity and mortality warrant further investigation.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...